Does TOFACITINIB Cause Joint swelling? 10,686 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 10,686 reports of Joint swelling have been filed in association with TOFACITINIB (XELJANZ XR). This represents 6.9% of all adverse event reports for TOFACITINIB.
10,686
Reports of Joint swelling with TOFACITINIB
6.9%
of all TOFACITINIB reports
1,703
Deaths
2,877
Hospitalizations
How Dangerous Is Joint swelling From TOFACITINIB?
Of the 10,686 reports, 1,703 (15.9%) resulted in death, 2,877 (26.9%) required hospitalization, and 2,028 (19.0%) were considered life-threatening.
Is Joint swelling Listed in the Official Label?
Yes, Joint swelling is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Malaise (9,040)
Rash (8,889)
What Other Drugs Cause Joint swelling?
ETANERCEPT (18,462)
ABATACEPT (18,453)
ADALIMUMAB (18,266)
METHOTREXATE (17,657)
TOCILIZUMAB (14,831)
LEFLUNOMIDE (13,026)
HYDROXYCHLOROQUINE (11,353)
RITUXIMAB (11,170)
INFLIXIMAB (9,853)
SULFASALAZINE (9,673)
Which TOFACITINIB Alternatives Have Lower Joint swelling Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN